Blaise Bratter

Blaise Bratter is the Chief Contributor to CannabisIntel. Being involved in the Australian cannabis industry since legalisation in 2016, he is now Operations Manager for ASX listed company MGC Pharmaceuticals.

Featured

THC Global gets a makeover

November 2, 2020

1.07K

THC Gobal Group (ASX: THC) has released their strategy plan,...

Featured Research

AusCann launches research support programme

October 28, 2020

1.01K

AusCann (ASX: AC8) has announced a research support programme for...

Featured Research

Zelira brings Hope to patients

October 27, 2020

1.02K

Zelira (ASX: ZLD) brings two new targeted medicinal cannabis medications...

Featured

MGC Pharma drop-ships medicinal cannabis to Brazil

October 13, 2020

932

MGC Pharma (ASX: MXC) has made history, becoming the first...

Featured

Lifespot Health receives cash injection

October 2, 2020

1.19K

Lifespot Health (ASX: LSH) has received a cash injection of...

Featured

Data reinforces logic showing positive treatment of CINV

September 30, 2020

307

Clinical trial results from a Phase II trial published in...

Featured

MGC Pharma advances Covid-19 trial

September 28, 2020

292

MGC Pharmaceuticals (ASX:MXC) continues to advance its clinical research on...

Featured

IHL achieves approval for Obstructive Sleep Apnoea trial

September 28, 2020

370

Incannex Healthcare (ASX:IHL) has received Human Research Ethics Committee (HREC)...

Featured Research

The Difference Between CBD Oil And Hemp Oil

August 11, 2020

351

If you haven't lived under a rock, you probably know...

Featured

Althea granted Hemp Cultivation Licence

June 6, 2019

1.24K

Althea (ASX: AGH) has been granted a Hemp Cultivation...

1 2 3 … 9

Page 1 of 9